Le Lézard
Classified in: Health, Science and technology, Business
Subjects: FNC, VEN

Trinity Capital Inc. Provides $15 Million in Growth Capital to restor3d


PHOENIX, June 5, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the commitment of $15 million in growth capital to restor3d, a 3D printing, patient specific medical device company.

restor3d enhances patient care and meets surgeons' needs by providing solutions tailored to patients' unique anatomies, enabling precise repair, reconstruction, and restoration. The company holds proprietary expertise in advanced 3D printing of osseointegrative materials, AI-based planning and design automation tools, and digital health solutions to provide seamless data-backed care to optimize individual patient outcomes.

"restor3d is at the forefront of innovation in the customized orthopedic implant industry with its unique patient specific 3D printed technologies," said Lauren Cosentino, Managing Director, Life Sciences at Trinity. "We look forward to working with restor3d's leadership team and supporting the company's continued growth." 

The new debt facility from Trinity will allow restor3d to continue its product innovation and expansion into new markets.

"We are thrilled to partner with Trinity as we continue to scale our business and bring our innovative, patient specific medical devices to more surgeons and patients worldwide," said Kurt Jacobus, Chief Executive Officer of restor3d. "This investment underscores the immense potential of our technology to transform patient care and drive better surgical outcomes."

About Trinity Capital Inc.

Trinity Capital Inc. (Nasdaq: TRIN), an internally managed business development company, is a leading provider of diversified financial solutions to growth-stage companies with institutional equity investors. Trinity Capital's investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans and equipment financings and equity-related investments. Trinity Capital believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience and track record in lending to growth stage companies. For more information, please visit the Company's website at www.trinitycap.com.

About restor3d, Inc.

restor3d is a world leader in patient specific musculoskeletal implants and driven by the belief that every patient deserves personalized care. The company holds proprietary expertise in 3D printing of osseointegrative materials, AI-based planning and design automation tools, and digital health solutions to provide seamless data-backed care to optimize individual patient outcomes. Alongside its customers, restor3d is reimagining the musculoskeletal reconstruction landscape. More information is available at www.restor3d.com.

SOURCE Trinity Capital Inc.


These press releases may also interest you

at 01:05
Regulatory News: BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced artificial intelligence (AI) to accelerate biopharma drug discovery, today announces a change to its Executive Leadership Team...

at 00:15
In the news release, AbbVie, Inc.'s Zymaxid tm Implicated in Product Liability Lawsuit Due to Risk of Serious Injury and Death, issued 02-Jul-2024 by Wormington & Bollinger over PRWeb, the source of the release should be "Wormington & Bollinger"...

at 00:00
Author David W. Treaster shares a Christian-based plan that can supplement a cancer patient's medical treatment plan in God Power Cancer Healing Plan: Spiritual Component ($15.99, paperback, 9781662899942; $7.99, e-book, 9781662899959). As long as...

2 jui 2024
In a groundbreaking medical feat, LiverIndia's Dr Karthik Mathivanan, a renowned Liver Transplant surgeon in Chennai with over 15 years of experience in multi-organ transplant surgery, has successfully utilised the emerging field of transplant...

2 jui 2024
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for 225Ac-FL-020, the company's lead radiopharmaceutical,...

2 jui 2024
Vitality Products Inc. (the "Company" or "Vitality"), a manufacturer, marketer and distributor of premium vitamins and supplements, is pleased to report its financial results for the first quarter ended April 30, 2024 and provide a business update....



News published on and distributed by: